## Abstract p53 is a human tumour suppressor which regulates multiple cellular processes, including cell growth, genomic stability and cell death. Recent works have demonstrated the bacterial redox protein azurin to enter cancer cells and induce apoptosis through p53 stabilization, resulting in a t
Modeling the interaction between the N-terminal domain of the tumor suppressor p53 and azurin
β Scribed by Monia Taranta; Anna Rita Bizzarri; Salvatore Cannistraro
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 395 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0952-3499
- DOI
- 10.1002/jmr.934
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
It is known that the half life of the tumor suppressor p53 can be increased by the interaction with the bacterial protein azurin, resulting in an enhanced antiβtumoral activity. The understanding of the molecular mechanisms on the basis of this phenomenon can open the way to new antiβcancer strategies. Some experimental works have given evidence of an interaction between p53 and azurin (AZ); however the binding regions of the proteins are still unknown. Recently, fluorescence studies have shown that p53 partakes in the binding with the bacterial protein by its Nβterminal (NT) domain. Here we have used a computational method to get insight into this interacting mode. The model that we propose for the best complex between AZ and p53 has been obtained from a rigidβbody docking, coupled with a molecular dynamics (MD) simulation, a free energy calculation, and validated by mutagenesis analysis. We have found a high degree of geometric fit between the two proteins that are kept together by several hydrophobic interactions and numerous hydrogen bonds. Interestingly, it has emerged that AZ binds essentially to the helices H~I~ and H~III~ of the p53 NT domain, which are also interacting regions for the foremost inhibitor of p53, MDM2. Copyright Β© 2009 John Wiley & Sons, Ltd.
π SIMILAR VOLUMES
An association between cyclin D3 and the C-terminal domain of pRb2/p130 was demonstrated using the yeast two-hybrid system. Further analysis restricted the epitope responsible for the binding within the 74 N-terminal amino acids of cyclin D3, independent of the LXCXE amino acid motif present in the
## Abstract In recent years, an impact of the p53 tumor suppressor protein in the processes of cellular and organismal ageing became evident. First hints were found in model organisms like __Saccharomyces cerevisiae__, __Caenorhabditis elegans__, and __Drosophila melanogaster__ where a clear connec
## Abstract The retinoblastoma tumor suppressor gene (__RB1__) is currently the only known gene whose mutation is necessary and sufficient for the development of a human cancer. Mutation or deregulation of RB1 is observed so frequently in other tumor types that compromising RB1 function may be a pr
## Abstract Peptides are valuable tools for studying proteinβprotein interactions, especially in cases of isolated protein domains and natively unfolded proteins. Here, we used peptides to quantitatively characterize the interaction between the natively unfolded HIVβ1 Tat protein and the tetrameriz
## Abstract Drug resistance remains a key obstacle to successful cancer treatment. The implementation of pharmacogenomics is widely proclaimed as a route to revolutionize the face of cancer therapy. Here we discuss the pharmacogenomics of the p53 tumor suppressor and its role in cancer chemosensiti